PF-05280014: Ph III REFLECTIONS B3271002 trial

Top-line data from the double-blind, international Phase III REFLECTIONS B3271002 trial in 690 patients with HER2-positive metastatic breast cancer showed that first-line treatment with PF-05280014 pl...